Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GE researchers begin in-depth study to understand Covid-19 impact on lungs
Bioscience researchers at GE Research have begun an in-depth study to better understand the impact of the Covid-19 virus on the lungs.
Research and Development (RD)
-
29 Jan 2021
-
28 Jan 2021
Existing drug offers targeted treatment for aggressive breast cancer
A new study claims palbociclib, an approved breast cancer drug, can treat an aggressive form of the cancer, bringing hope to thousands of afflicted women in the UK.
-
26 Jan 2021
Merck discontinues Covid-19 vaccine candidates on grounds of poor performance
American pharma giant Merck has announced that it has discontinued the development of its SARS-CoV-2/Covid-19 vaccine candidates V590 and V591, after they performed poorly in phase 1 clinical trials.
-
20 Jan 2021
Novartis, GSK team up for $3.6m genetic diversity research in Africa
Swiss pharma giant Novartis and British pharmaceuticals company GSK have teamed up to conduct scientific research linking genetic diversity in Africa and its potential impact on response to drug therapeutics.
-
19 Jan 2021
Cure Genetics, Boehringer to develop AAV vectors for gene therapy
Chinese biotechnology firm Cure Genetics has partnered with Boehringer Ingelheim for the development of novel Adeno-Associated Virus (AAV) vectors to be used in gene therapies.